31/01/2008 13:00:00

John LaCour to Speak at the Credit Union Technology Risk Management and Security Summit

MarkMonitor(R), the global leader in enterprise brand protection,

today announced John LaCour, director of AntiPhishing Solutions for

MarkMonitor, will speak at the at the Credit Union Technology Risk

Management and Security Summit in Austin, Texas on February 4.

LaCour will address emerging cybercrime threats in 2008, such as

Rock Phish kits, fast flux networks, and other phishing tactics.

MarkMonitor data shows phishers are targeting a greater breadth of

institutions, with credit unions experiencing 32.6 percent of phishing

attacks in Q3. The MarkMonitor Autumn 2007 Brandjacking Index includes

evidence of increasingly automated phishing site deployment and

management, including techniques to make phishing sites more

resilient. The Credit Union Technology Risk Management and Security

Summit is the largest gathering of information security managers in

the credit union industry. Security experts in the credit union

industry will join LaCour to speak on topics that relate to managing,

analyzing, and preventing risks.

Who: John LaCour, director of AntiPhishing Solutions for

MarkMonitor

What: Credit Union Technology Risk Management and Security Summit,

"Emerging Cybercrime Threats in 2008"

http://www.cuispa.org/cuispa2008/index.php

When: Mon., February 4, 11:15 a.m. CT

Where: Hyatt Regency, 208 Barton Springs Road, Austin, TX 78704

For more information regarding this event, please contact Te Smith

at 831-818-1267 or te.smith@markmonitor.com.

About MarkMonitor

MarkMonitor, the global leader in enterprise brand protection,

offers comprehensive solutions and services that safeguard brands,

reputation and revenue from online risks. With end-to-end solutions

that address the growing threats of online fraud, brand abuse and

unauthorized channels, MarkMonitor enables a secure Internet for

businesses and their customers. The company´s exclusive access to data

combined with its real-time prevention, detection and response

capabilities provide wide-ranging protection to the ever-changing

online risks faced by brands today. For more information, visit

www.markmonitor.com.

Editor´s Notes: MarkMonitor(R) is a registered trademark of

MarkMonitor, Inc. All other trademarks included herein are the

property of their respective owners.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
20 Nov
VELO
Nogle brugere (Pav3 og ebdrups især) har skrevet lidt om FDA's afvisning af Envarsus. Jeg vil gerne ..
47
22 Nov
VWS
Hejsa Mena.  nu har jeg observeret at du kommer i meget spændende diagologer med de fleste skribente..
37
19 Nov
BIOPOR
  Her følger mine tanker efter Bioporto Q3 regnskab samt efterfølgende investor præsentation   Omsæt..
22
18 Nov
VWS
Normal 0 21 false false false DA X-NONE X-NONE ..
22
22 Nov
VWS
tauser, det korte svar er:......................................................................... ..
21
20 Nov
OW
Jeg er rystet over at OW Bunkers bestyrelse er rystet.   OW Bunkers bestyrelse har i dag via Altor ..
21
19 Nov
VWS
stop nu det børnehave pjat i er jo ikke en døjt bedre selv. Pokerchamp har ændret fint stil fra tidl..
17
18 Nov
EI
Opsang til EI   Det er efterhånden en børnehave i mange af trådene herinde, og jeg kan ikke forstå a..
17
18 Nov
GEN
Nå, GEN fik ikke sneget sig ind i late-breaking abstracts på en Gilead sponsoreret idelalisib+ofatum..
15
22 Nov
VWS
jeg tænker at der er ingen grund til at du er politikvinde her. Hvorfor skal du "bestemme" hvad folk..
14

Tech Companies Send Criticism Along With NSA-Related Data -- Update

04/02/2014 00:06:00
By Danny Yadron Technology companies including Google Inc. and Microsoft Corp. released new figures on the amount of data requests they received from U.S. ..

U.S. Hot Stocks: Hot Stocks to Watch

03/02/2014 14:07:00
Among the companies with shares expected to actively trade in Monday's session is Herbalife Ltd. (HLF). Herbalife Ltd. (HLF) raised its fourth-quarter outl..

Pfizer Study Meets Primary Endpoints

03/02/2014 13:05:00
Pfizer Inc. (PFE) said Monday that a Phase 2 trial of its advanced breast cancer treatment met its primary endpoint. Pfizer said a study comparing the effec..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Announcement No. 17
Euroinvestor around the globe: Euroinvestor.dk | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 November 2014 18:31:11
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20141120.1 - EUROWEB5 - 2014-11-23 19:31:11 - 2014-11-23 18:31:11 - 1000 - Website: OKAY